Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.20USD
13 Aug 2018
Change (% chg)

$-0.02 (-7.72%)
Prev Close
$0.22
Open
$0.20
Day's High
$0.22
Day's Low
$0.20
Volume
164,535
Avg. Vol
94,652
52-wk High
$1.52
52-wk Low
$0.20

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.53 -- --
ROI: -95.74 1.78 14.61
ROE: -149.70 3.28 16.33

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

17 Apr 2018

BRIEF-Regulus Qtrly Net Loss Per Share $0.14

* REGULUS REPORTS FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PIPELINE UPDATE

07 Mar 2018

Competitors

Earnings vs. Estimates